tiprankstipranks
DBV Technologies S.A. - American Depositary Shares (DBVT)
NASDAQ:DBVT
US Market
DBVT
DBV Technologies SA - American
RESEARCH TOOLSreports
Want to see DBVT full AI Analyst Report?

DBV Technologies SA - American (DBVT) Earnings Dates, Call Summary & Reports

449 Followers

Earnings Data

Report Date
Jul 29, 2026
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.11
Last Year’s EPS
-0.31
Same Quarter Last Year
Analyst Consensus
Moderate Buy
Based on 6 Analysts Ratings

Earnings Call Summary

Q2 2024
Earnings Call Date:Jul 30, 2024|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call presents a positive outlook with significant progress in Viaskin Peanut development and financial management. However, regulatory challenges and increased operating expenses pose some concerns. The overall sentiment is cautiously optimistic with a positive tilt due to successful trial milestones and extended cash runway.
Company Guidance
During the DBV Technologies Q2 2024 earnings call, the company provided several key updates on its development programs and financial outlook. DBV is advancing its Viaskin Peanut candidate for treating peanut allergies in children aged 1 to 7. The VITESSE Phase III trial for children aged 4 to 7 is progressing well, with patient enrollment expected to complete by the end of Q3 2024. The company is also addressing the FDA's feedback on its COMFORT Toddlers supplemental safety study, which supports the Biologics License Application for the 1 to 3 age group. Additionally, DBV Technologies has extended its cash runway into Q1 2025 due to cost-saving measures, despite a net loss of $60.5 million in H1 2024. The company remains focused on achieving regulatory approval and advancing its clinical trials, with anticipated milestones set for the remainder of the year.
Viaskin Peanut Development Progress
Successful results from the Phase III efficacy study, EPITOPE, for toddlers aged 1 to 3 years met its primary endpoint. Enrollment for the VITESSE Phase III trial in children aged 4 to 7 years is expected to complete by the end of Q3 2024.
Cash Runway Extension
Due to cost-saving measures, DBV Technologies has extended its cash runway into Q1 of 2025, an extension from the previous estimate of year-end 2024.
Financial Efficiency
Operating income for the first semester of 2024 reached $2.6 million, with efforts to maximize efficiency and maintain disciplined cash management.

DBV Technologies SA - American (DBVT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
Daily Earnings Calendar >

DBVT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 29, 2026
2026 (Q2)
-0.11 / -
-0.31―――
Apr 30, 2026
2026 (Q1)
-0.13 / -0.11
-0.2657.69% (+0.15)――
Mar 26, 2026
2025 (Q4)
-0.18 / -0.24
-0.240.00% (0.00)――
Oct 28, 2025
2025 (Q3)
-0.32 / -0.24
-1.685.00% (+1.36)――
Jul 29, 2025
2025 (Q2)
-0.18 / -0.31
-1.781.76% (+1.39)――
Apr 30, 2025
2025 (Q1)
-0.24 / -0.26
-2.890.71% (+2.54)――
Mar 24, 2025
2024 (Q4)
-0.22 / -0.24
-1.280.00% (+0.96)――
Nov 06, 2024
2024 (Q3)
-1.80 / -1.60
-1.75.88% (+0.10)――
Jul 30, 2024
2024 (Q2)
-2.23 / -1.70
-2.634.62% (+0.90)―
May 07, 2024
2024 (Q1)
-2.10 / -2.80
-2.2-27.27% (-0.60)――
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DBVT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 30, 2026
$21.00$19.87-5.38%
Mar 26, 2026
$20.21$20.00-1.04%
Oct 28, 2025
$15.55$15.21-2.19%
Jul 29, 2025
$9.80$9.40-4.12%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does DBV Technologies S.A. - American Depositary Shares (DBVT) report earnings?
DBV Technologies S.A. - American Depositary Shares (DBVT) is schdueled to report earning on Jul 29, 2026, TBA (Confirmed).
    What is DBV Technologies S.A. - American Depositary Shares (DBVT) earnings time?
    DBV Technologies S.A. - American Depositary Shares (DBVT) earnings time is at Jul 29, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DBVT EPS forecast?
          DBVT EPS forecast for the fiscal quarter 2026 (Q2) is -0.11.